SABCS 2023: Shining a New Light on Breast Cancer

Описание: Innovative session moderated by Dr. David Mankoff focused on advances in molecular and functional imaging in breast cancer. Discussion provided by Drs. Farrokh Dehdashti and Amy Fowler.
PS05-01 Accuracy and safety of fibroblast activation protein inhibitor (FAPI) PET/CT in diagnosis of axillary lymph node metastasis in early breast cancer patients: a prospective cohort study (PFB-01&02 study). Zhixin Hao
PS05-02 PET Imaging of PARP Expression as a Biomarker of Response to Chemotherapy in Breast Cancer: A Nonrandomized Clinical Trial. Sarah Gitto
PS05-03 MagSense® HER2, a Molecularly Targeted Magnetic Resonance Imaging Agent for the Detection of Axillary Nodal Metastasis in Subjects with Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer. Isaac Bright
PS05-04 [89Zr]Trastuzumab-PET/MRI to Characterize HER2+ Breast Cancer: A Quantitative Approach on Tumor Heterogeneity. Ameer Mansur
PS05-06 Outcomes of Surveillance using Contrast Enhanced Mammography in Women with a Personal History of Breast Cancer. Julia Matheson
PS05-07 Early prediction of response to Neoadjuvant Immunotherapy in Triple Negative Breast Cancer (TNBC) with DCE-MRI. Gaiane Rauch
PS05-08 Restriction Spectrum Imaging MRI for automated evaluation of response to neoadjuvant therapy in breast cancer. Maren Marie Sjaastad Andreassen
PS05-09 A single-arm Phase II clinical study of fulvestrant combined with chemotherapy in the neoadjuvant treatment of HR+/HER2- locally advanced breast cancer. Xiahua Zeng